Spinzer Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 41 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -55.85%
(FY 2022)
- Profit 80.39%
(FY 2022)
- Ebitda 73.18%
(FY 2022)
- Net Worth -6.94%
(FY 2022)
- Total Assets 5.73%
(FY 2022)
About Spinzer Pharmaceuticals
The Corporate was formerly known as Lark Cosmed Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Viney Uppal, Kamal Anand, and Beena Gupta serve as directors at the Company.
- CIN/LLPIN
U74899DL1983PTC015530
- Company No.
015530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Spinzer Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viney Uppal  | Director | 11-Apr-1983 | Current |
| Kamal Anand | Director | 27-Aug-2012 | Current |
| Beena Gupta | Director | 30-Aug-1997 | Current |
Financial Performance and Corporate Structure Insights of Spinzer Pharmaceuticals.
Spinzer Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 55.85% decrease. The company also saw a substantial improvement in profitability, with a 80.39% increase in profit. The company's net worth dipped by a decrease of 6.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spinzer Pharmaceuticals?
Unlock access to Spinzer Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spinzer Pharmaceuticals?
Unlock and access historical data on people associated with Spinzer Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spinzer Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spinzer Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
